Extracorporeal Membrane Oxygenation Machine Market size was valued at USD 527.02 million in 2024 and is set to exceed USD 899.72 million by 2037, expanding at over 4.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of extracorporeal membrane oxygenation machine is evaluated at USD 544.73 million.
The primary growth driver for the market is the increasing prevalence of respiratory disorders. Respiratory diseases such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, and pneumonia are on the rise worldwide. Therefore, extracorporeal membrane oxygenation machine which provide vital life support to patients with compromised lung function, have witnessed a substantial surge.
According to the World Health Organization (WHO), respiratory system-related diseases are responsible for global morbidity and mortality.
Traditional ventilator support is proved to be insufficient in severe respiratory failure cases. Moreover, the extracorporeal membrane oxygenation machine provide advanced respiratory assistance by oxygenating the blood outside the body. Further, the ECMO machine market can experience a hike due to events such as pandemics or large-scale health crises since these machine are crucial in supporting patients with severe respiratory distress.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
4.2% |
|
Base Year Market Size (2024) |
USD 527.02 million |
|
Forecast Year Market Size (2037) |
USD 899.72 million |
|
Regional Scope |
|
Type (Veno-Venous, Veno-Arterial, Arterio-Venous)
The veno-arterial segment in the extracorporeal membrane oxygenation machine market is estimated to gain the largest revenue share of 60% in the year 2037. Veno arterial (VA) extracorporeal membrane oxygenation machine is an integral part of heart transplantation protocols since it provides vital support to the patient during the critical period between organ harvesting and implantation.
This use of VA ECMO extends the viability of donor hearts by ensuring optimal conditions for successful transplantation. Nearly 0.1 million patients are hospitalized due to cardiogenic shock in the U.S. every year and VA ECMO is the most widely used by cardiologists for complete and immediate support for cardiac arrest.
The growth of the market in this segment is driven by its integral role in addressing cardiac emergencies, and seamlessly integrating into heart transplantation protocols.
End Users (Hospitals, Specialty Clinics, Emergency Medical Services)
The hospital segment is expected to garner a significant share in the year 2037. Government initiatives that are enhancing critical care infrastructure in hospitals are contributing to the growth of extracorporeal membrane oxygenation machine utilization.
Additionally, the increased funding for the expansion and refurbishment of critical care units is enabling hospitals to invest in innovative life support technologies, including ECMO machine. The government allocates critical care infrastructure, signifying the prioritization of resources for advanced technologies like these in hospitals.
Overall, the hospital segment in the market is thriving due to the increasing extensiveness of critical cases and rising utilization for pediatric cases.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
End User |
|
Asia Pacific Market Statistics
The extracorporeal membrane oxygenation machine market in the Asia Pacific region is projected to hold the largest revenue\ share of 36% by the end of 2037. Collaborations and partnerships among the extracorporeal membrane oxygenation machine manufacturers and local healthcare institutions in the region are promoting technology transfer in different countries.
On top of that, these collaborations enhance the accessibility of advanced extracorporeal membrane oxygenation machine technologies and ensure that the region benefits from the latest developments in the medical field. India has one of the world's largest insurance schemes named the Ayushman BharatPradhan Mantri Jan Aroya Yojana launched in 2017 is poised to meet the universal health requirements and achieve sustainable development goals.
Such schemes play very pivotal role in lifting the medical sector and advance equipment including extracorporeal membrane oxygenation machine. The market in the region is further witnessing robust growth driven by factors such as the increasing incidence of respiratory diseases, initiatives by the government, and advancements in healthcare infrastructure.
North American Market Analysis
The ECMO machine market in the North American region is projected to hold the second largest share during the projection period 2024-2037. The region encounters a high prevalence of cardiovascular diseases that contribute significantly to the demand for extracorporeal membrane oxygenation machine. Also, conditions such as severe heart failure and post-cardiotomy shock require necessary advanced life support for the patient and extracorporeal membrane oxygenation machine emerges as a vital intermediate in managing these critical cases effectively. The region is a hub for technological advancements in healthcare.
According to the New York State Department of Health, nearly 0.7 million people die due to heart disorders or strokes every year. Therefore, the market benefits from a high number of deaths happening due to heart diseases, and continuous advancements, like improved membrane materials, enhanced pump technologies, and sophisticated monitoring systems. These supreme innovations in healthcare contribute to the efficiency, safety, and effectiveness of extracorporeal membrane oxygenation machine therapy.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?